Literature DB >> 22320363

Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: incidence, predictors, and prognostic significance.

Ju-Sing Fan1, Hsien-Hao Huang, Yen-Chia Chen, David Hung-Tsang Yen, Wei-Fong Kao, Mu-Shun Huang, Chun-I Huang, Chen-Hsen Lee.   

Abstract

OBJECTIVES: The objective was to explore the incidence, predictors, and prognostic significance of emergency department (ED) neurologic deterioration in patients with spontaneous intracerebral hemorrhage (SICH).
METHODS: This was a retrospective cohort study conducted at the ED, neurocritical care unit, and general intensive care unit of a university-affiliated medical center. Consecutive adult SICH patients treated in our ED from January 2002 through December 2009 were included, identified from the registered stroke data bank. These were cross-checked for coding with International Classification of Diseases, Ninth Revision, Clinical Modification 431 and 432.9. Enrolled patients had SICH with elapsed times of <12 hours and Glasgow Coma Scale (GCS) scores ≥ 13 on arrival. ED neurologic deterioration was defined as having a two-or-more-point decrease in consciousness noted in any GCS score assessment between ED presentation and admission. Comparisons of numerical data were performed using an unpaired t-test (parametric data) or Mann-Whitney U-test (nonparametric data). Comparisons of categorical data were done by chi-square tests. Variables with p < 0.1 in univariate analysis were further analyzed using multiple logistic regression. No variable automated or manual selection methods were used.
RESULTS: Among the 619 patients with SICH included in the study, 22.6% had ED neurologic deterioration. Independent predictors for ED neurologic deterioration included regular antiplatelet use, ictus to ED arrival time under 3 hours, initial body temperature ≥ 37.5°C, intraparenchymal hemorrhage associated with intraventricular hemorrhage (IVH), and presence of a midline shift of greater than 2 mm on computed tomography (CT). ED neurologic deterioration was associated with 1-week mortality, 30-day mortality, and poor neurologic outcome on discharge.
CONCLUSIONS: Nearly one-quarter of SICH patients with an initial GCS of 13 to 15 had a two points or more deterioration of their GCS while in the ED. ED neurologic deterioration was associated with death and poor neurologic outcomes on discharge. Several risk factors that are available early in the patients' courses appear to be associated with ED neurologic deterioration. By identifying patients at risk for early neurologic decline and intervening early, physicians may be able to improve patient outcomes.
© 2012 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22320363     DOI: 10.1111/j.1553-2712.2011.01285.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  21 in total

Review 1.  Steps to consider in the approach and management of critically ill patient with spontaneous intracerebral hemorrhage.

Authors:  Daniel Agustin Godoy; Gustavo Rene Piñero; Patricia Koller; Luca Masotti; Mario Di Napoli
Journal:  World J Crit Care Med       Date:  2015-08-04

2.  Defining the Optimal Midline Shift Threshold to Predict Poor Outcome in Patients with Supratentorial Spontaneous Intracerebral Hemorrhage.

Authors:  Wen-Song Yang; Qi Li; Rui Li; Qing-Jun Liu; Xing-Chen Wang; Li-Bo Zhao; Peng Xie
Journal:  Neurocrit Care       Date:  2018-06       Impact factor: 3.210

3.  Combination of Intra-Hematomal Hypodensity on CT and BRAIN Scoring Improves Prediction of Hemorrhage Expansion in ICH.

Authors:  Joshua VanDerWerf; Donna Kurowski; James Siegler; Taneeta Ganguly; Brett Cucchiara
Journal:  Neurocrit Care       Date:  2018-08       Impact factor: 3.210

4.  Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH.

Authors:  Gui-Nv He; Hao-Zhan Guo; Xiong Han; En-Feng Wang; Yan-Qiu Zhang
Journal:  J Neurol       Date:  2018-06-15       Impact factor: 4.849

5.  Thrombin disrupts vascular endothelial-cadherin and leads to hydrocephalus via protease-activated receptors-1 pathway.

Authors:  Xiao-Di Hao; Chen-Sheng Le; Hong-Mei Zhang; De-Sheng Shang; Lu-Sha Tong; Feng Gao
Journal:  CNS Neurosci Ther       Date:  2019-04-07       Impact factor: 5.243

6.  Prolonged stay of spontaneous intracranial hemorrhage patients in the emergency department is correlated with worse outcomes.

Authors:  Qian He; Rui Guo; Ke Zhang; Chao You; Yi Liu; Zhi Zeng
Journal:  World J Emerg Med       Date:  2022

7.  Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial.

Authors:  Kristina Shkirkova; Jeffrey L Saver; Sidney Starkman; Gregory Wong; Julius Weng; Scott Hamilton; David S Liebeskind; Marc Eckstein; Samuel Stratton; Frank Pratt; Robin Conwit; Nerses Sanossian
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

8.  New avenues for treatment of intracranial hemorrhage.

Authors:  Shruti Sonni; Vasileios-Arsenios Lioutas; Magdy H Selim
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

Review 9.  Clinical and Radiographic Predictors of Intracerebral Hemorrhage Outcome.

Authors:  Fawaz Al-Mufti; Ahmad M Thabet; Tarundeep Singh; Mohammad El-Ghanem; Krishna Amuluru; Chirag D Gandhi
Journal:  Interv Neurol       Date:  2018-01-12

10.  Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.

Authors:  Zhe Kang Law; Michael Desborough; Ian Roberts; Rustam Al-Shahi Salman; Timothy J England; David J Werring; Thompson Robinson; Kailash Krishnan; Robert Dineen; Ann Charlotte Laska; Nils Peters; Juan Jose Egea-Guerrero; Michal Karlinski; Hanne Christensen; Christine Roffe; Daniel Bereczki; Serefnur Ozturk; Jegan Thanabalan; Rónán Collins; Maia Beridze; Philip M Bath; Nikola Sprigg
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.